Advancing Cell & Gene

Experience groundbreaking in-person events, engaging online activities, and cutting-edge digital services that unite influential and passionate leaders with scientific experts, collectively shaping the future of cell & gene.

In-Person & Online Events

Collaborate & Partner for a Better Future

Explore Cell & Gene

Unite with the cell & gene industry's foremost leaders and scientific experts through our year-round activities. Immerse yourself in cutting-edge scientific content that sparks thought-provoking insights, providing a unique perspective on the latest R&D trends and challenges.

Resources & Announcements


Upstream & Downstream Bioprocessing

Is Single-Use Bioprocessing the Way Forward?

12/06/24 - Danish company Novo Holdings has acquired a majority stake in the Austrian-based company Single Use Support, marking a critical stride towards the wider adoption of single-use bioprocessing tools.
02/05/24 - A recent study shows that a novel refractometry-based PAT system monitors metabolic activity during CGT production, revealing insights into optimising bioprocesses.
30/04/24 - Cell & Gene 2024 Conference Producer Anya Chuykov met with Stephen Sullivan, COO of iPSirius, to discuss the advancements being made by iPSirius, and their unique proprietary technology working to treat aggressive forms of cancer.
03/04/24 - Scarlet Therapeutics uses genetic manipulation of red blood cells to carry a higher load of therapeutic proteins to help treat rare metabolic diseases.
27/03/24 - A study conducted by the Broad Institute and the Massachusetts Institute of Technology (MIT) demonstrated that when multi-tailed mRNAs were integrated into a CRISPR-Cas9 system they proved to be more efficient gene editors than unmodified mRNA.
08/03/24 - Cell therapy for solid tumours is an innovative cancer treatment that uses a patient's own immune cells or donor cells to fight cancer, but its effectiveness varies by tumour type and patient's immune system. Although it offers new hope, it poses risks such as cytokine release syndrome and neurotoxicity. Recent advancements have led to better targeting, combination therapies, and next-generation treatments, with future research aimed at improving safety, effectiveness, and accessibility, potentially revolutionising cancer care.

Online Activities


27/06/24 | Science Exchange

Addressing the Challenges of Cell and Gene Therapy Translation: From Lab to Patient

Oxford Global PLUS Pass

Introducing the PLUS Pass – your exclusive 12-month, all-access gateway to over 40 prestigious events hosted annually across the UK, Europe, and the US.

Tailored for experts, thought-leaders, and scientists from global pharma & biotech, the PLUS Pass not only grants you entry to our curated event experiences but also offers boundless knowledge sharing through our robust PLUS Platform. Immerse yourself in a wealth of on-demand event recordings, content articles, and industry news, while engaging in thought-provoking exclusive webinars and stimulating group discussions each month.

Oxford Global PLUS

Services

Driving impact, awareness, and business generation

Our extensive and engaged community extends across large, mid-size and innovative start-ups within the pharma and biotech space, with a dedicated audience spanning a range of specialisms. Whether you have content to share, are looking for ways to enhance your brand visibility or would like to increase engagement with prospective customers, Oxford Global can offer valuable access to your target demographic through our range of event & content services.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things cell & gene